Bo
Boundless Bio
San Diego CAFounded 201860 employees
Private CapbiotechPrivateOncology
Platform: ecDNA
Market Cap
N/A
All Drugs
2
Clinical Trials
6
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Rimatinib | BOU-2608 | NDA/BLA | 2 | VEGF | ADHDSCLC | ||
| Mirinesiran | BOU-1713 | Phase 3 | 4 | DLL3 | MS |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)